Early Morphological Changes Produced by Anti-inflammatory Steroids on Tissue Culture Fibroblasts*  by Berliner, David L et al.
The fibroblast, a widely distributed cell of
mesenchymal origin, is the most abundant cell
type of loose connective tissue (1). Although
these cells participate in many functions, their
name refers to their ability to elaborate connec-
tive tissue fibers. The fibroblast's major activity
is exhibited in the formation of new connective
tissue components during growth, regeneration
and repair (2). These cells have been shown, by
Dougherty et at., to play a major part during
the development of inflammatory reactions (3—
5). Fibroblasts are extremely sensitive target
cells to anti-inflammatory steroids (6—8). The
growth inhibitory effects of anti-inflammatory
steroids on conective tissue cells in vitro (6—10)
and in vivo (11, 12) is a well-known phenome-
non. The following is a description of the early
morphological changes occurring in tissue cul-
ture fibroblasts, in the presence of the most po-
tent naturally occurring steroid, cortisol, and the
most potent topical synthetic anti-inflammatory
steroid, fluocinolone acetonide (13—15).
METHODS
Fibroblast L-929 were grown in Eagle's media
supplemented with 10% calf serum, 100 i.u. of peni-
cillin, and 100 jg of streptomycin sulfate per ml.
The steroids used were dissolved in 2 l of propy-
lene glycol to give final concentrations of 12 g of
fluocinolone acetonide; 5.0 ig of cortisol; 10 g of
tetrahydrocortisol and 10 g of il-deoxycortisol
per ml of growth media. Figure 1 represents the
chemical structures of steroids used in the present
study.
Twenty-five thousand fibroblasts were inoculated
into Leighton tubes containing cover slips (10 x
35 mm) and allowed to grow for 48 hours. Then
each cover slip was removed from the tube and
rinsed with warm media (media + vehicle for the
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controls and media + steroid solution for the ex-
perimentals), mounted on a standard microscopic
slide, following with the addition of a small
amount of the corresponding media. The cover slip
was sealed with petrolatum and immediately
placed in a temperature controlled microscope at
38° C. Photographic procedures were initiated im-
mediately after the locating of suitable cells. Phase
contrast photomicrographs were taken at 15 min-
ute intervals during four hours.
The steroid solution was in contact with the cells
from the time of their removal from the Leighton
tubes until the end of the period of observation.
RESULTS
To conserve space, we will not present the
complete sequence of photomierographs. Pic-
tures 1 to 6 represent the sequence of events
occurring in fibroblasts in the presence of nor-
mal media. Picture 1 shows the appearance of
the culture at the beginning of the observation.
Picture 2 was taken 30 minutes later. Pictures
3, 4, 5 and 6 were taken at one hour intervals.
During this time, all cells presented the normal
characteristic shape and motility of L-929 fibro-
blasts. This control study demonstrates the via-
bility of the cells during the entire period of
observation.
Pictures 7 through 12 show the progressive
changes occurring at the same time interval as
shown in the controls (30 minutes; 1, 2, 3, and
4 hours) in the presence of 5.0 g of cortisol
per ml of growth media. Notice the regression
of cytoplasmic prolongation during the latter
part of the experiment.
Pictures 13 to 18 show the cellular changes
in the presence of 1.2 g of fluocinolone aceto-
nide. The time intervals are the same as in the
control series. At 30 minutes there is little
change as compared to time zero. After one hour
(Picture 15) the smaller fibroblasts start to
show a definite change in shape; however, the
larger ones still remain more or less unchanged.
In Pictures 17 and 18 (3 and 4 hours, respec-
tively) the size and shape of all the fibroblasts
in the preparation have shown considerable
change. The reduction in size, greater refrac-
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Fluocinolone Acetonide
tility, and some globular forms of the small and
medium size fibroblasts is clearly shown. Note-
worthy is the shortening of cytoplasmie pro-
longations. Fibroblasts treated with tetrahydro-
cortisol and li-deoxycortisol do not show any
change in morphology, but behave in a manner
similar to the controls.
DIsCUssION
The fibroblast has been shown to be a very
sensitive target cell for corticosteroids (6—8, 12).
It has been demonstrated previously that for-
mation of collagen and mucopolysaccharides by
fibroblasts is inhibited in the presence of corti-
costeroids (17, 18). Also, the direct influence of
anti-inflammatory steroids on fibroblasts seems
to play a protective role during the develop-
ment of inflammatory processes (3, 5). Steroid
induced morphological fibroblastic changes in
normal and inflammed tissue in vivo (3—5) are
similar to the ones observed in this study in
vitro. Holden and Adams (8) have previously
described the shortening of terminal processes
of tissue culture cells as well as the tendency of
cellular aggregation, when treated with high con-
centration of anti-inflammatory steroids (10—50
jig of cortisol per ml). Ruhmann and Berliner
(6) have shown the same phenomenon, observing
the maximum effect five days after treatment
with 0.1 g of cortisol per ml. Utilizing fluocino-
lone acetonide at concentrations of 0.00075 g
per ml, duplication of these morphological
changes can be obtained (6). A bioassay proce-
dure has been developed by which the structure-
activity relationship of various anti-inflamma-
tory steroids can be correlated with their growth
inhibitory effects upon tissue culture fibroblasts
(19).
In the present study we are describing the
earliest time at which we can obtain this phe-
nomenon. After 3 hours of treatment with corti-
sol or 1 hour with fluocinolone acetonide, some
morphological changes in tissue culture fibro-
blasts are apparent. Loss of the characteristic
spindle-like shape, as a result of increased cellu-
lar refractivity and the assumption of smaller
globular forms. Smaller amounts of fluocinolone
acetonide than cortisol are needed to produce
similar morphological fibroblastic alterations.
Treatments of these cells with other steroids
such as tetrahydrocortisol and 1 1-deoxycortisol
does not induce similar morphological changes.
11- Deoxycortisol
Tetrahydro-Cortisol
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PICTURES 1 To 6. Normal L-929 fibroblast. High power approximately X 369
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PICTURES 7 TO 12. Cortisol treated L-929 fibroblast. High power approximately )< 855
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PICTURES 13 TO 18. Fluocinolone acetonide treated L-929 fibroblasts. High power approxi-
mately >< 369.
Moreover, these compounds are not active anti-
inflammatory agents. At this time, it is difficult
to correlate the mechanism of the cells' rounding
up with the salutary effectiveness of corticos-
teroids as anti-inflammatory agents. While other
agents may cause flbroblasts to round up, in-
flammatory steroids like fluocinolone acetonide
appear to initiate this process as an essential
part of their antiphiogistic activity. In inflam-
mation it has been postulated by Dougherty
at al., (3—5, 20) that the rounding up effect pro-
dueed by anti-inflammatory steroids upon fibro-
blasts is a protective one. This morphologic form
appears to enable the fibroblast to resist the
chain reaction of cell destruction initiated by
the inflammatory agent and the cytotoxic prod-
ucts elaborated during inflammation. An inter-
esting correlation can be obtained, since the
same structure-activity relationships exist in the
in vivo studies on corticosteroid anti-inflamma-
tory activity as in the in vitro studies presented
in the present investigation.
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SUMMARY
Fibroblasts L-929 grown in tissue culture, ex-
hibited the typical morphological characteristics
when treated with active anti-inflammatory
steroids. The same phenomenon has been de-
scribed to occur in vivo. These morphological
changes consist in the formation of round fibro-
blasts. Fluoeinolone aeetonide produces this ef-
feet at lower concentration and at an earlier
time than cortisol.
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